“That’s a demand that utterly outstrips the supply that we have.” — Jim Jackson, PsyD, of Vanderbilt University Medical Center in Nashville, on a study suggesting that many COVID survivors have post-traumatic stress disorder.
“It’s like taking a football and shoving it into a pipe with the diameter of a golf ball.” — David Nauen, MD, PhD, of Johns Hopkins University in Baltimore, about the unexpected presence of megakaryocytes in the brain capillaries of people who died with COVID-19.
“This is one of those findings where you can hear it at [the Genitourinary Cancers Symposium] and take it to the clinic on Monday.” — Sumanta Pal, MD, of City of Hope Comprehensive Cancer Center in Duarte, California, discussing a new option for a rare type of kidney cancer.
“There’s a certain amount of hedging and equivocating.” — Mark Collins, a high school art teacher in suburban Chicago, commenting on the recently updated CDC guidance on schools’ reopening during the pandemic.
“Understanding what predicts their mental health is really critical in thinking about how we’re going to have a workforce that doesn’t quit.” — Elizabeth Linos, PhD, of the University of California Berkeley, on how physician mothers are experiencing significant rates of moderate to severe anxiety during the COVID-19 crisis.
“There might be different etiologies for different people; it might not be just one thing.” — Allison Navis, MD, of Icahn School of Medicine at Mount Sinai in New York City, about what causes COVID-19 symptoms to persist for months.